Next Article in Journal / Special Issue
Regulation of Neuronal Protein Trafficking and Translocation by SUMOylation
Previous Article in Journal
Genetic Fingerprinting of Wheat and Its Progenitors by Mitochondrial Gene orf256
Previous Article in Special Issue
Sumoylation at the Host-Pathogen Interface
Article Menu

Export Article

Open AccessReview
Biomolecules 2012, 2(2), 240-255;

The Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer

Department of Medical Oncology, University of Thessaly School of Medicine, University Hospital of Larissa, Biopolis 41110, Larissa, Greece
Author to whom correspondence should be addressed.
Received: 15 March 2012 / Revised: 28 March 2012 / Accepted: 9 April 2012 / Published: 23 April 2012
(This article belongs to the Special Issue Protein SUMOylation)
Full-Text   |   PDF [291 KB, uploaded 23 April 2012]   |  


SUMO (small ubiquitin-related modifier) conjugation is a reversible three-step process of protein post-translational modifications mediating protein-protein interactions, subcellular compartmentalization and regulation of transcriptional events. Among divergent transcription factors regulated by SUMOylation and deSUMOylation, the androgen receptor (AR) is of exceptional significance, given its established role in prostate carcinogenesis. The enzymes of the SUMO pathway can have diverse effects on AR transcriptional activity, either via direct modification of the AR or through modification of AR co-regulators. Accumulating in vitro and in vivo evidence implicates the SUMO pathway in AR-dependent signaling. Prostate cancer cell proliferation and hypoxia-induced angiogenesis are also regulated by the SUMO pathway, through an AR-independent mechanism. Thus, an important role has been revealed for members of the SUMO pathway in prostate cancer (PCa) development and progression, offering new therapeutic targets. View Full-Text
Keywords: SUMO; SENP; androgen receptor; prostate cancer SUMO; SENP; androgen receptor; prostate cancer

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Vlachostergios, P.J.; Papandreou, C.N. The Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer. Biomolecules 2012, 2, 240-255.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Biomolecules EISSN 2218-273X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top